Literature DB >> 24504579

Nerve decompression after diabetic foot ulceration may protect against recurrence: a 3-year controlled, prospective analysis.

D Scott Nickerson1, Andrew J Rader.   

Abstract

BACKGROUND: Nerve entrapment, common in diabetes, is considered an associated phenomenon without large consequence in the development of diabetes complications such as ulceration, infection, amputation, and early mortality. This prospective analysis, with controls, of the ulcer recurrence rate after operative nerve decompression (ND) offers an objective perspective on the possibility of frequent occult nerve entrapment in the diabetic foot complication cascade.
METHODS: A multicenter cohort of 42 patients with diabetic sensorimotor polyneuropathy, failed pharmacologic pain control, palpable pulses, and at least one positive Tinel's nerve percussion sign was treated with unilateral multiple lower-leg external neurolyses for the indication of pain. All of the patients had healed at least one previous ipsilateral plantar diabetic foot ulceration (DFU). This group was retrospectively evaluated a minimum of 12 months after operative ND and again 3 years later. The recurrence risk of ipsilateral DFU in that period was prospectively analyzed and compared with new ulcer occurrence in the contralateral intact, nonoperated control legs.
RESULTS: Operated legs developed two ulcer recurrences (4.8%), and nine contralateral control legs developed ulcers (21.4%), requiring three amputations. Ulcer risk is 1.6% per patient per year in ND legs and 7% in nonoperated control legs (P = .048).
CONCLUSIONS: Adding operative ND at lower-leg fibro-osseous tunnels to standard postulcer treatment resulted in a significantly diminished rate of subsequent DFU in neuropathic high-risk feet. This is prospective, objective evidence that ND can provide valuable ongoing protection from DFU recurrence, even years after primary ulcer healing.

Entities:  

Mesh:

Year:  2014        PMID: 24504579     DOI: 10.7547/0003-0538-104.1.66

Source DB:  PubMed          Journal:  J Am Podiatr Med Assoc        ISSN: 1930-8264


  8 in total

Review 1.  Reconsidering nerve decompression: an overlooked opportunity to limit diabetic foot ulcer recurrence and amputation.

Authors:  D Scott Nickerson
Journal:  J Diabetes Sci Technol       Date:  2013-09-01

2.  Australian guideline on prevention of foot ulceration: part of the 2021 Australian evidence-based guidelines for diabetes-related foot disease.

Authors:  Michelle R Kaminski; Jonathan Golledge; Joel W J Lasschuit; Karl-Heinz Schott; James Charles; Jane Cheney; Anita Raspovic
Journal:  J Foot Ankle Res       Date:  2022-07-06       Impact factor: 3.050

3.  Illustration of Cost Saving Implications of Lower Extremity Nerve Decompression to Prevent Recurrence of Diabetic Foot Ulceration.

Authors:  Timothy M Rankin; John D Miller; Angelika C Gruessner; D Scott Nickerson
Journal:  J Diabetes Sci Technol       Date:  2015-06-08

Review 4.  Biologic Basis of Nerve Decompression Surgery for Focal Entrapments in Diabetic Peripheral Neuropathy.

Authors:  John Sessions; D Scott Nickerson
Journal:  J Diabetes Sci Technol       Date:  2014-02-27

5.  Our experience of reinnervation of sole in diabetic sensorimotor polyneuropathy: A chance to change the natural history of disease.

Authors:  Pawan Agarwal; Dhananjaya Sharma
Journal:  J Clin Orthop Trauma       Date:  2021-01-29

6.  Tarsal tunnel release restores sensations in sole for diabetic sensorimotor polyneuropathy.

Authors:  Pawan Agarwal; Bashudev Sharma; Dhananjaya Sharma
Journal:  J Clin Orthop Trauma       Date:  2019-08-16

Review 7.  Nerve decompression and neuropathy complications in diabetes: Are attitudes discordant with evidence?

Authors:  D Scott Nickerson
Journal:  Diabet Foot Ankle       Date:  2017-09-06

Review 8.  Decompression nerve surgery for diabetic neuropathy: a structured review of published clinical trials.

Authors:  James W Albers; Ryan Jacobson
Journal:  Diabetes Metab Syndr Obes       Date:  2018-09-24       Impact factor: 3.168

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.